Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians

Journal of Diabetes and its Complications

Volumn 21, Issue 4, 2007, Pages 237-241

  Movva, Sireesha ^a   Alluri, Ravindra V ^b   Komandur, Sreelatha ^b   Vattam, Kiran ^b   Eppa, Kavitha ^b   Mukkavali, Kamal K ^b   Mubigonda, Somashekhar ^a   Saharia, Sarbeshwar ^a   Shastry, Jandayala C ^b   Hasan, Qurratulain ^a,b  

^a Mahavir Hospital   (India)

^b KAMINENI HOSPITALS   (India)

Author keywords

ACE gene polymorphism; Angiotensin II; Angiotensin converting enzyme; Diabetic nephropathy; Gene polymorphisms; Type 2 diabetes mellitus

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; SERUM ALBUMIN;

ADULT; ALLELE; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; URINALYSIS;

ADULT; ALLELES; ASIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 34347268789     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.07.001     Document Type: Article

References (29)

1. Alluri R.V., Mohan V., Komandur S., Chawda K., Chaudhuri J.R., and Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: A hospital based study. European Journal of Neurology 12 (2005) 40-44
2. Arzu Ergen H., Hatem H., Agachan B., Camlica H., and Isbir T. Angiotensin-1 converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Experimental & Molecular Medicine 36 (2004) 345-350
3. Ballerman B.J., Zeidel M.L., Gunning M.E., and Brenner B.M. Vasoactive peptides and the kidney. In: Brenner B.M., and Rector F.C. (Eds). The kidney (1991), W.B. Saunders, Philadelphia 510-583
4. Bertrand L.J., Brain J.G.P., Joseph V.B., and Vaidhyanathapuram Balakrishnan S. Polymorphisms of host response genes: Implications in the pathogenesis and treatment of acute renal failure. Kidney International 67 (2005) 14-33
5. Dong-Hwa T., Yi-Der J., Kwan-Dun W., Tong-Yang T., and Lee-Ming C. Platelet collagen receptor α2β1 integrin and glycoprotein IIIa PlA1/A2 polymorphisms are not associated with nephropathy in type 2 diabetes. American Journal of Kidney Diseases 38 (2001) 1185-1190
6. Fujisawa T., Ikegami H., Kawaguchi Y., Uda H., Shintani M., Fukuda M., et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41 (1998) 47-53
7. Grzeszczak W., Zychma M.J., Lacka B., and Zukowska-Szczechowska E.J. Angiotensin I-converting enzyme gene polymorphism: Relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. Journal of the American Society of Nephrology 9 (1998) 1664-1669
8. Gutierrez C., Vendrell J., Pastor R., Llor C., Aguilar C., Broch M., and Richart C. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 46 (1997) 976-980
9. Ha S.K., Park H.C., Park H.S., Kang B.S., Lee T.H., Hwang H.J., et al. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: Effect of ACE gene DD on the progression of diabetic nephropathy. American Journal of Kidney Diseases 41 (2003) 943-949
10. Hasan Q., Mohan V., and Ahuja Y.R. (CTG)n expansion at DMPK locus seen only in muscle tissue: A novel case. Indian Journal of Experimental Biology 42 (2004) 937-940
11. Hsieh M.C., Lin S.R., Hsiah T.J., Hsu C.H., Chen H.C., Shin S.J., and Tsai J.H. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrology, Dialysis, Transplantation 15 (2000) 1008-1013
12. Kennefick T.M., and Anderson S. Role of angiotensin II in diabetic nephropathy. Seminars in Nephrology 7 (1999) 441-447
13. Kumar A., Mohindru K., and Sehajpal P.K. Angiotensin-I converting enzyme polymorphism and diabetic nephropathy in North India. International Journal of Human Genetics 5 (2005) 279-283
14. Kunz R., Bork J.P., Fritsche L., Ringel J., and Sharma A.M. Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy, a methodologic appraisal and systemic review. Journal of the American Society of Nephrology 9 (1998) 1653-1663
15. -) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney International 55 (1999) 1843-1848
16. Long D.A., Price K.L., Herrera-Acosta J., and Johnson R.J. How does angiotensin II cause renal injury?. Hypertension 43 (2004) 722
17. Moczulski D., Fojcik H., Zukowska-Szczechowska E., Szydlowska I., and Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrology, Dialysis, Transplantation 18 (2003) 1535-1540
18. Mohan V., Ponnala S., Gujjari K., Boddu P., Shankar R., Prasad R., et al. DNA methylation in esophageal pathologies including cancer: Special reference to hMLH1 gene promotor status. Tumori 92 (2006) 155-162
19. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40 (2002) 35-40
20. Pasha M.A.Q., Khan A.P., Kumar R., Kumar R., Ram R.B., Grover S.K., Srivastava S.S., et al. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. Journal of Bioscience 27 (2002) 67-70
21. Pradeepa R., and Mohan V. The changing scenario of the diabetes epidemic, implications for India. Indian Journal of Medical Research 116 (2002) 121-132
22. Raptis A.E., and Viberti G. Pathogenesis of diabetic nephropathy. Experimental and Clinical Endocrinology & Diabetes 2 (2001) 424-437
23. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels. Journal of Clinical Investigation 86 (1990) 1343-1346
24. Ruger B.M., Hasan Q., Greenhill N.S., Davis P.F., Dunbar P.R., and Neale T.J. Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 39 (1996) 1215-1222
25. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. Journal of Neurology, Neurosurgery, and Psychiatry 64 (1998) 227-230
26. Vishwanathan V., Zhu Y., Bala K., Dunn S., Snehalatha C., Ramachandran A., et al. Association between ACE gene polymorphism and diabetic nephropathy in south Indian patients. Journal of the Pancreas 2 (2001) 83-87 [online]
27. Wang Y., Ng M.C.Y., So W.Y., Tong P.C.Y., Ma R.C.W., Chow C.C., et al. Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 28 (2005) 348-354
28. Werner H., Shen-Orr Z., Stannard B., Burguera B., Roberts C.T., and LeRoith D. Experimental diabetes increases insulin like growth factor I and II receptor concentration and gene expression in kidney. Diabetes 39 (1990) 1490-1497
29. Wolf G., and Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications. Kidney International 67 (2005) 799-812